Skip to main content
Log in

Overview

CNS Drugs provides researchers and healthcare professionals with essential information on the most important aspects of drug therapies used for the management of neurological and psychiatric disorders.

Via a program of reviews and original research articles, the journal addresses major issues relating to drug therapy of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of neurological and psychiatric disorders; and the practical management of specific clinical situations.

As a hybrid journal, CNS Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.

CNS Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Editor
  • Susan Pochon
Impact factor
6.0 (2022)
5 year impact factor
6.2 (2022)
Submission to first decision (median)
8 days
Downloads
812,876 (2023)

Latest articles

Journal updates

  • Digital Features

    CNS Drugs is able to host a range of digital features, with a number of options available to authors.

Journal information

Electronic ISSN
1179-1934
Print ISSN
1172-7047
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. CLOCKSS
  6. CNKI
  7. CNPIEC
  8. Chemical Abstracts Service (CAS)
  9. Current Contents/Clinical Medicine
  10. Current Contents/Life Sciences
  11. Dimensions
  12. EBSCO
  13. EMBASE
  14. Google Scholar
  15. Japanese Science and Technology Agency (JST)
  16. Medline
  17. Naver
  18. OCLC WorldCat Discovery Service
  19. Pathway Studio
  20. Portico
  21. ProQuest
  22. PsycINFO
  23. Reaxys
  24. SCImago
  25. SCOPUS
  26. Science Citation Index Expanded (SCIE)
  27. Semantic Scholar
  28. TD Net Discovery Service
  29. UGC-CARE List (India)
  30. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG

Navigation